Fund page
FONDMAPFRE BOLSA MIXTO, FI
Portfolio as of 2025-12-31. Source: periodic filing with the CNMV. View original filing (PDF)
Full portfolio
Every position in the latest periodic filing, largest weight first. Aggregates ("other equities...") are baskets of small positions the filing itself does not break out line by line.
This period's moves
H2 2025 vs H1 2025 (estimated)
− ACCIONES|COVESTROAG
Leaves the portfolio; it was 2.67% of weight.
− ACCIONES|UNILEVER
Leaves the portfolio; it was 2.57% of weight.
− ACCIONES|CELLNEX
Leaves the portfolio; it was 1.53% of weight.
− ITALIA
Leaves the portfolio; it was 0.37% of weight.
− BOAM
Leaves the portfolio; it was 0.35% of weight.
− FRANCIA
Leaves the portfolio; it was 0.26% of weight.
− SKAENS
Leaves the portfolio; it was 0.26% of weight.
− ACCFIL
Leaves the portfolio; it was 0.26% of weight.
− BRO_BANKT_ES
Leaves the portfolio; it was 0.24% of weight.
− INGGROEPNV
Leaves the portfolio; it was 0.24% of weight.
− DANSKEMORTGA
Leaves the portfolio; it was 0.22% of weight.
− FRANCIA
Leaves the portfolio; it was 0.21% of weight.
− ITALIA
Leaves the portfolio; it was 0.21% of weight.
− CARREFOUR
Leaves the portfolio; it was 0.18% of weight.
− TESORO
Leaves the portfolio; it was 0.17% of weight.
− FRANCIA
Leaves the portfolio; it was 0.16% of weight.
− ATTINC
Leaves the portfolio; it was 0.15% of weight.
− DEVOLKSBANKN
Leaves the portfolio; it was 0.14% of weight.
− SANTCONSBANK
Leaves the portfolio; it was 0.14% of weight.
− BRO_BNPPA_FR
Leaves the portfolio; it was 0.14% of weight.
− ITALIA
Leaves the portfolio; it was 0.10% of weight.
− BRO_RABOB_NL
Leaves the portfolio; it was 0.10% of weight.
− SKAENS
Leaves the portfolio; it was 0.10% of weight.
− FRANCIA
Leaves the portfolio; it was 0.06% of weight.
− TORONTODOMBA
Leaves the portfolio; it was 0.05% of weight.
▲ ACCIONES|GLAXOSMITH
Goes from 1.08% to 1.37%.
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It also focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases; and strategic research collaboration with Engitix Ltd. to identify and validate novel therapeutic targets driving liver fibrosis regression. The company has a strategic alliance with AN2 Therapeutics, Inc. for the development of new therapies for TB. GSK plc was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. The company was founded in 1715 and is headquartered in London, United Kingdom.
View company page →Fixed income
Maturity ladder
Observed contractual maturity of each position, repos excluded. Matured/≤3 months includes bonds maturing in the first days after the period close.
Top issuers
The 10 issuers with the largest declared exposure in this fund, repos excluded.
Top instruments
The 10 instruments with the largest declared exposure. No yield, IRR or rating: there's no reliable data to compute them.
This period's fixed-income moves
Compares the current fixed-income portfolio with the previous period, by ISIN. An exit that coincides with maturity isn't a sale: the bond reached its contractual date.
+ FRANCIA
Enters the portfolio at 2.52% weight.
+ BRO_CREIN_FR
Enters the portfolio at 0.34% weight.
+ FRANCIA
Enters the portfolio at 0.11% weight.
+ IRENSPAITTUR
Enters the portfolio at 0.28% weight.
+ MIZUHOFINAN
Enters the portfolio at 0.28% weight.
+ ITALIA
Enters the portfolio at 0.05% weight.
+ EASYJETFINCO
Enters the portfolio at 0.25% weight.
+ SKAENS
Enters the portfolio at 0.25% weight.
+ CREDITAGRICO
Enters the portfolio at 0.23% weight.
+ ITALIA
Enters the portfolio at 0.21% weight.
+ BRO_SANTA_ES
Enters the portfolio at 0.19% weight.
+ ORANO SA
Enters the portfolio at 0.19% weight.
+ FCCAQUALIA
Enters the portfolio at 0.19% weight.
+ VODAFOINTDAC
Enters the portfolio at 0.19% weight.
+ CELLNEXFINAN
Enters the portfolio at 0.18% weight.
+ FRANCIA
Enters the portfolio at 0.17% weight.
+ INTESA
Enters the portfolio at 0.14% weight.
+ GALPENERGIA
Enters the portfolio at 0.14% weight.
+ RCIBANQUESA
Enters the portfolio at 0.14% weight.
+ BMW US
Enters the portfolio at 0.13% weight.
+ WELLS FARGO
Enters the portfolio at 0.12% weight.
+ WESTPACSECNZ
Enters the portfolio at 0.10% weight.
+ CONTINENTALA
Enters the portfolio at 0.10% weight.
+ NYKREDITREAL
Enters the portfolio at 0.10% weight.
+ CRHSMWFINDAC
Enters the portfolio at 0.10% weight.
+ AIRLIQFINCE
Enters the portfolio at 0.09% weight.
+ RESEAUDETRAN
Enters the portfolio at 0.09% weight.
+ AMPRIONGMBH
Enters the portfolio at 0.09% weight.
+ MSTANLEYEMIS
Enters the portfolio at 0.09% weight.
+ FRANCIA
Enters the portfolio at 0.09% weight.
+ BRO_CAIXA_ES
Enters the portfolio at 0.05% weight.
+ UNICREDIT SPA
Enters the portfolio at 0.05% weight.
− ITALIA
Leaves the portfolio; it was 0.21% of weight.
− FRANCIA
Leaves the portfolio; it was 0.16% of weight.
− FRANCIA
Leaves the portfolio; it was 0.26% of weight.
− ITALIA
Leaves the portfolio; it was 0.37% of weight.
− FRANCIA
Leaves the portfolio; it was 0.06% of weight.
− SKAENS
Leaves the portfolio; it was 0.26% of weight.
− TESORO
Leaves the portfolio; it was 0.17% of weight.
− FRANCIA
Leaves the portfolio; it was 0.21% of weight.
− ITALIA
Leaves the portfolio; it was 0.10% of weight.
◦ BOAM
Leaves the portfolio; it was 0.35% of weight.
◦ ACCFIL
Leaves the portfolio; it was 0.26% of weight.
◦ BRO_BANKT_ES
Leaves the portfolio; it was 0.24% of weight.
◦ INGGROEPNV
Leaves the portfolio; it was 0.24% of weight.
◦ DANSKEMORTGA
Leaves the portfolio; it was 0.22% of weight.
◦ CARREFOUR
Leaves the portfolio; it was 0.18% of weight.
◦ ATTINC
Leaves the portfolio; it was 0.15% of weight.
◦ DEVOLKSBANKN
Leaves the portfolio; it was 0.14% of weight.
◦ SANTCONSBANK
Leaves the portfolio; it was 0.14% of weight.
◦ BRO_BNPPA_FR
Leaves the portfolio; it was 0.14% of weight.
◦ BRO_RABOB_NL
Leaves the portfolio; it was 0.10% of weight.
◦ SKAENS
Leaves the portfolio; it was 0.10% of weight.
◦ TORONTODOMBA
Leaves the portfolio; it was 0.05% of weight.
Disclaimer
This is not financial advice. The portfolio comes from the periodic report the fund files with the CNMV and lags the real close of the period: it is a snapshot of the end of each half-year, not a real-time portfolio.